Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?

Han RC., Fry LE., Kantor A., McClements ME., Xue K., MacLaren RE.

DOI

10.1080/21678707.2021.1882300

Type

Journal article

Journal

Expert Opinion on Orphan Drugs

Publisher

Informa UK Limited

Publication Date

02/01/2021

Volume

9

Pages

13 - 24

Permalink Original publication